-
1دورية أكاديمية
المؤلفون: Keizman D; Department of Oncology, Meir Medical Center, Kfar Saba, Israel. Electronic address: danielkeizman@gmail.com., Ish-Shalom M; Department of Oncology, Meir Medical Center, Kfar Saba, Israel., Sella A; Department of Oncology, Asaf Harofe Medical Center, Zerifin, Israel., Gottfried M; Department of Oncology, Meir Medical Center, Kfar Saba, Israel., Maimon N; Department of Oncology, Meir Medical Center, Kfar Saba, Israel., Peer A; Department of Oncology, Rambam Medical Center, Haifa, Israel., Hammers H; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Eisenberger MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Sinibaldi V; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD., Neiman V; Department of Oncology, Rabin Medical Center, Petach-Tikva, Israel., Rosenbaum E; Department of Oncology, Rabin Medical Center, Petach-Tikva, Israel., Sarid D; Department of Oncology, Tel Aviv Sourasky Medical center, Tel Aviv, Israel., Mermershtain W; Department of Oncology, Soroka Medical Center, Beer-Sheva, Israel., Rouvinov K; Department of Oncology, Soroka Medical Center, Beer-Sheva, Israel., Berger R; Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel., Carducci MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
المصدر: Clinical genitourinary cancer [Clin Genitourin Cancer] 2016 Oct; Vol. 14 (5), pp. 420-425. Date of Electronic Publication: 2016 Apr 27.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Renal Cell/*drug therapy , Diabetes Mellitus/*drug therapy , Indoles/*administration & dosage , Kidney Neoplasms/*drug therapy , Metformin/*administration & dosage , Pyrroles/*administration & dosage, Aged ; Aged, 80 and over ; Comorbidity ; Disease-Free Survival ; Female ; Humans ; Indoles/therapeutic use ; Male ; Metformin/therapeutic use ; Middle Aged ; Neoplasm Metastasis ; Proportional Hazards Models ; Pyrroles/therapeutic use ; Retrospective Studies ; Sunitinib ; Treatment Outcome